The home of a prominent Bayer executive was targeted last week in an alleged arson in New Jersey, law enforcement sources ...

Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against ...

Bayer's CEO is facing increasing investor pressure to deliver on turnaround efforts and reverse a forecast earnings decline ...

Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

The stock plunged by as much as 10% in intraday trading on Friday with investors balking at the size of a cash call as ...

Bayer's CEO, Bill Anderson, faces escalating investor scrutiny to reverse the company's forecasted earnings decline. Tasked ...

While Bayer’s consumer and crop science divisions continued to slide—both in the fourth quarter and in 2024 overall—the ...

Bayer reveals phase 3 data for improved MRI contrast agent Bayer is close to filing a new MRI contrast agent that can reduce levels of gadolinium, which can have health and environmental consequences.

The center, which broke ground in 2023 in the Beijing Economic-Technological Development Area — aka Beijing E-Town — is the ...

SALES FORECAST: The German pharmaceutical and agricultural conglomerate is expected to post sales of 11.26 billion euros ($11.71 billion) for the quarter ended December, according to a Vara Research ...

Berlin: Bayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned subsidiary of Bayer AG, ...